These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34671128)

  • 1. Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study.
    Xie SH; Santoni G; Lagergren J
    Br J Cancer; 2022 Jan; 126(1):129-133. PubMed ID: 34671128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopausal hormone therapy and the risk of esophageal and gastric cancer.
    Brusselaers N; Maret-Ouda J; Konings P; El-Serag HB; Lagergren J
    Int J Cancer; 2017 Apr; 140(7):1693-1699. PubMed ID: 28006838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance proton pump inhibition therapy and risk of oesophageal cancer.
    Brusselaers N; Engstrand L; Lagergren J
    Cancer Epidemiol; 2018 Apr; 53():172-177. PubMed ID: 29477057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study.
    Zheng J; Xie SH; Santoni G; Lagergren J
    Br J Cancer; 2019 Nov; 121(10):877-882. PubMed ID: 31591459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of anti-androgenic 5α-reductase inhibitors and risk of oesophageal and gastric cancer by histological type and anatomical sub-site.
    Rabbani S; Santoni G; Lagergren J; Xie SH
    Br J Cancer; 2022 Sep; 127(5):892-897. PubMed ID: 35715630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?
    Pandeya N; Webb PM; Sadeghi S; Green AC; Whiteman DC;
    Gut; 2010 Jan; 59(1):31-8. PubMed ID: 19875392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopausal hormone therapies and risk of colorectal cancer: a Swedish matched-cohort study.
    Liu Q; Simin J; Debelius J; Fall K; Sadr-Azodi O; Engstrand L; Williams C; Brusselaers N
    Aliment Pharmacol Ther; 2021 Jun; 53(11):1216-1225. PubMed ID: 33857339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study.
    Vaughan TL; Dong LM; Blount PL; Ayub K; Odze RD; Sanchez CA; Rabinovitch PS; Reid BJ
    Lancet Oncol; 2005 Dec; 6(12):945-52. PubMed ID: 16321762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden.
    Chandanos E; Lindblad M; Jia C; Rubio CA; Ye W; Lagergren J
    Br J Cancer; 2006 Jul; 95(1):118-22. PubMed ID: 16755290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer.
    Shore R; Yu J; Ye W; Lagergren J; Rutegård M; Akre O; Stattin P; Lindblad M
    Sci Rep; 2021 Jun; 11(1):13486. PubMed ID: 34188067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy is associated with gastro-oesophageal reflux disease: a retrospective cohort study.
    Close H; Mason JM; Wilson D; Hungin AP
    BMC Gastroenterol; 2012 May; 12():56. PubMed ID: 22642788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.
    Masclee GM; Coloma PM; Spaander MC; Kuipers EJ; Sturkenboom MC
    BMJ Open; 2015 Jan; 5(1):e006640. PubMed ID: 25633286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis.
    Abnet CC; Freedman ND; Kamangar F; Leitzmann MF; Hollenbeck AR; Schatzkin A
    Br J Cancer; 2009 Feb; 100(3):551-7. PubMed ID: 19156150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and oral contraceptives and risk of oesophageal adenocarcinoma: a systematic review and meta-analysis.
    Lagergren K; Lagergren J; Brusselaers N
    Int J Cancer; 2014 Nov; 135(9):2183-90. PubMed ID: 24676860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between menopausal hormone therapy use and mortality risk: a Swedish population-based matched cohort study.
    Simin J; Khodir H; Fornes R; Tamimi RM; Brusselaers N
    Acta Oncol; 2022 May; 61(5):632-640. PubMed ID: 35129052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer.
    Macfarlane TV; Murchie P; Watson MC
    Cancer Epidemiol; 2015 Dec; 39(6):1015-22. PubMed ID: 26590503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of hormonal and reproductive factors with differentiated thyroid cancer risk in women: a pooled prospective cohort analysis.
    O'Grady TJ; Rinaldi S; Michels KA; Adami HO; Buring JE; Chen Y; Clendenen TV; D'Aloisio A; DeHart JC; Franceschi S; Freedman ND; Gierach GL; Giles GG; Lacey JV; Lee IM; Liao LM; Linet MS; McCullough ML; Patel AV; Prizment A; Robien K; Sandler DP; Stolzenberg-Solomon R; Weiderpass E; White E; Wolk A; Zheng W; Berrington de Gonzalez A; Kitahara CM
    Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 38110618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin or statin use in relation to survival after surgery for esophageal cancer: a population-based cohort study.
    Holmberg D; Gottlieb-Vedi E; Hedberg J; Lindblad M; Mattsson F; Lagergren J
    BMC Cancer; 2023 Apr; 23(1):375. PubMed ID: 37098462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis.
    Cronin-Fenton DP; Murray LJ; Whiteman DC; Cardwell C; Webb PM; Jordan SJ; Corley DA; Sharp L; Lagergren J;
    Eur J Cancer; 2010 Jul; 46(11):2067-76. PubMed ID: 20456945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal hormone therapy and biliary tract cancer: a population-based matched cohort study in Sweden.
    Kilander C; Lagergren J; Konings P; Sadr-Azodi O; Brusselaers N
    Acta Oncol; 2019 Mar; 58(3):290-295. PubMed ID: 30656997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.